These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 31620161)

  • 1. New Ratios for Performance Improvement for Identifying Acyl-CoA Dehydrogenase Deficiencies in Expanded Newborn Screening: A Retrospective Study.
    Wang B; Zhang Q; Gao A; Wang Q; Ma J; Li H; Wang T
    Front Genet; 2019; 10():811. PubMed ID: 31620161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the C14:1/Medium-Chain Acylcarnitine Ratio Instead of C14:1 to Reduce False-Positive Results for Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency in Newborn Screening in Japan.
    Tajima G; Aisaki J; Hara K; Tsumura M; Kagawa R; Sakura F; Sasai H; Yuasa M; Shigematsu Y; Okada S
    Int J Neonatal Screen; 2024 Feb; 10(1):. PubMed ID: 38390979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card.
    Wood JC; Magera MJ; Rinaldo P; Seashore MR; Strauss AW; Friedman A
    Pediatrics; 2001 Jul; 108(1):E19. PubMed ID: 11433098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four Years' Experience in the Diagnosis of Very Long-Chain Acyl-CoA Dehydrogenase Deficiency in Infants Detected in Three Spanish Newborn Screening Centers.
    Merinero B; Alcaide P; Martín-Hernández E; Morais A; García-Silva MT; Quijada-Fraile P; Pedrón-Giner C; Dulin E; Yahyaoui R; Egea JM; Belanger-Quintana A; Blasco-Alonso J; Fernandez Ruano ML; Besga B; Ferrer-López I; Leal F; Ugarte M; Ruiz-Sala P; Pérez B; Pérez-Cerdá C
    JIMD Rep; 2018; 39():63-74. PubMed ID: 28755359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newborn screening for medium chain acyl-CoA dehydrogenase deficiency: performance improvement by monitoring a new ratio.
    Hall PL; Wittenauer A; Hagar A
    Mol Genet Metab; 2014 Dec; 113(4):274-7. PubMed ID: 25454677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequencing from dried blood spots in infants with "false positive" newborn screen for MCAD deficiency.
    McCandless SE; Chandrasekar R; Linard S; Kikano S; Rice L
    Mol Genet Metab; 2013 Jan; 108(1):51-5. PubMed ID: 23151387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biochemical and molecular characteristics among infants with abnormal newborn screen for very-long-chain acyl-CoA dehydrogenase deficiency: A single center experience.
    Upadia J; Noh G; Lefante JJ; Andersson HC
    Mol Genet Metab Rep; 2023 Dec; 37():101002. PubMed ID: 37671074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nationwide retrospective observational study of population newborn screening for medium-chain acyl-CoA dehydrogenase (MCAD) deficiency in the Netherlands.
    Jager EA; Kuijpers MM; Bosch AM; Mulder MF; Gozalbo ER; Visser G; de Vries M; Williams M; Waterham HR; van Spronsen FJ; Schielen PCJI; Derks TGJ
    J Inherit Metab Dis; 2019 Sep; 42(5):890-897. PubMed ID: 31012112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diversity in the incidence and spectrum of organic acidemias, fatty acid oxidation disorders, and amino acid disorders in Asian countries: Selective screening vs. expanded newborn screening.
    Shibata N; Hasegawa Y; Yamada K; Kobayashi H; Purevsuren J; Yang Y; Dung VC; Khanh NN; Verma IC; Bijarnia-Mahay S; Lee DH; Niu DM; Hoffmann GF; Shigematsu Y; Fukao T; Fukuda S; Taketani T; Yamaguchi S
    Mol Genet Metab Rep; 2018 Sep; 16():5-10. PubMed ID: 29946514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for medium chain acyl-CoA dehydrogenase deficiency using electrospray ionisation tandem mass spectrometry.
    Clayton PT; Doig M; Ghafari S; Meaney C; Taylor C; Leonard JV; Morris M; Johnson AW
    Arch Dis Child; 1998 Aug; 79(2):109-15. PubMed ID: 9797589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of short-chain acyl-CoA dehydrogenase (SCAD) deficiency: Exploring the role of new variants including the first SCAD-disease-causing allele carrying a synonymous mutation.
    Tonin R; Caciotti A; Funghini S; Pasquini E; Mooney SD; Cai B; Proncopio E; Donati MA; Baronio F; Bettocchi I; Cassio A; Biasucci G; Bordugo A; la Marca G; Guerrini R; Morrone A
    BBA Clin; 2016 Jun; 5():114-9. PubMed ID: 27051597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Equine biochemical multiple acyl-CoA dehydrogenase deficiency (MADD) as a cause of rhabdomyolysis.
    Westermann CM; de Sain-van der Velden MG; van der Kolk JH; Berger R; Wijnberg ID; Koeman JP; Wanders RJ; Lenstra JA; Testerink N; Vaandrager AB; Vianey-Saban C; Acquaviva-Bourdain C; Dorland L
    Mol Genet Metab; 2007 Aug; 91(4):362-9. PubMed ID: 17540595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An unusually high frequency of SCAD deficiency caused by two pathogenic variants in the ACADS gene and its relationship to the ethnic structure in Slovakia.
    Lisyová J; Chandoga J; Jungová P; Repiský M; Knapková M; Machková M; Dluholucký S; Behúlová D; Šaligová J; Potočňáková Ľ; Lysinová M; Böhmer D
    BMC Med Genet; 2018 Apr; 19(1):64. PubMed ID: 29678161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: High Incidence of Detected Patients With Expanded Newborn Screening Program.
    Remec ZI; Groselj U; Drole Torkar A; Zerjav Tansek M; Cuk V; Perko D; Ulaga B; Lipovec N; Debeljak M; Kovac J; Battelino T; Repic Lampret B
    Front Genet; 2021; 12():648493. PubMed ID: 33986768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis for substrate fatty acyl chain specificity: crystal structure of human very-long-chain acyl-CoA dehydrogenase.
    McAndrew RP; Wang Y; Mohsen AW; He M; Vockley J; Kim JJ
    J Biol Chem; 2008 Apr; 283(14):9435-43. PubMed ID: 18227065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a Tandem Mass Spectrometry Method for Rapid Measurement of Medium- and Very-Long-Chain Acyl-CoA Dehydrogenase Activity in Fibroblasts.
    Bouvier D; Vianey-Saban C; Ruet S; Acquaviva C
    JIMD Rep; 2017; 35():71-78. PubMed ID: 27943070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
    Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
    Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening.
    Merritt JL; Vedal S; Abdenur JE; Au SM; Barshop BA; Feuchtbaum L; Harding CO; Hermerath C; Lorey F; Sesser DE; Thompson JD; Yu A
    Mol Genet Metab; 2014 Apr; 111(4):484-92. PubMed ID: 24503138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutation analysis in mitochondrial fatty acid oxidation defects: Exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship.
    Gregersen N; Andresen BS; Corydon MJ; Corydon TJ; Olsen RK; Bolund L; Bross P
    Hum Mutat; 2001 Sep; 18(3):169-89. PubMed ID: 11524729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood acylcarnitine levels in normal newborns and heterozygotes for medium-chain acyl-CoA dehydrogenase deficiency: a relationship between genotype and biochemical phenotype?
    Lehotay DC; LePage J; Thompson JR; Rockman-Greenberg C
    J Inherit Metab Dis; 2004; 27(1):81-8. PubMed ID: 14970748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.